Targeted IL-15 drug in patient testing revives exhausted T cells without triggering severe inflammation (opens in new tab)
For some people, cancer immunotherapies are life-changing. These treatments can turn the body's own immune system against a tumor, either eliminating it or shrinking it enough to make surgery possible. But these therapies don't work for everyone, can gradually stop working, or can come with a host of side effects, including severe inflammation.
Read the original article